About OmniaMed

OmniaMed has educated more than 20,000 GPs alone since 2003 and our expertise doesn't stop there.

With experience across a number of specialist therapy areas as well as medicines management and commissioning, our educational meetings deliver expert insight and the latest developments to support healthcare professionals in providing optimal patient care.

Follow Us @OmniaMedUK

[29/08/2016 21:07] - Elevated total bilirubin negatively associated with major diabetic complications - senile diabetic patients bit.ly/2c4YZSW

[29/08/2016 19:20] - Sanofi's Phase III Results could make Praluent the next Blockbuster Cholesterol Drug bit.ly/2bV2MV6